
### [NCIT:C96756](http://purl.obolibrary.org/obo/NCIT_C96756)
**Label:** Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm

**Subclasses:** [NCIT:C96760](http://purl.obolibrary.org/obo/NCIT_C96760) (Inflammatory Hepatocellular Adenoma), [NCIT:C96761](http://purl.obolibrary.org/obo/NCIT_C96761) (Unclassified Hepatocellular Adenoma), [NCIT:C3758](http://purl.obolibrary.org/obo/NCIT_C3758) (Hepatocellular Adenoma), [NCIT:C96759](http://purl.obolibrary.org/obo/NCIT_C96759) (Beta-Catenin-Activated Hepatocellular Adenoma), [NCIT:C96826](http://purl.obolibrary.org/obo/NCIT_C96826) (Biliary Adenofibroma), 

**Class expressions from DL-Learner:**

- [UBERON:0006925](http://purl.obolibrary.org/obo/UBERON_0006925) (digestive system gland) 66.67%
- [UBERON:0002107](http://purl.obolibrary.org/obo/UBERON_0002107) (liver) 66.67%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 66.67%
- Thing 51.13%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 25.37%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 22.29%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 22.12%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 21.12%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 21.10%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.90%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 18.45%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 18.02%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 17.79%


